# SCRIMED Commercial Growth Engine Brief Status: commercial-growth-engine-active Growth plays: 6 Execute-now plays: 2 Conversion lanes: 4 Revenue proof steps: 5 Growth bottlenecks: 4 Proof routes: 25 Revenue authority: not-revenue-guarantee Securities authority: not-securities-offering-material Investment advice: not-investment-advice PHI authority: not-authorized-production-phi Clinical care authority: not-authorized-live-care ## Boundary SCRIMED Commercial Growth Engine organizes buyer segments, sellable offers, revenue motions, proof routes, conversion actions, bottlenecks, and retained approval gates for synthetic evaluations, readiness assessments, and protected enterprise pilots. It is growth execution readiness only. It is not a customer revenue guarantee, investment advice, securities offering material, audited financial reporting, valuation assurance, legal advice, tax advice, reimbursement assurance, procurement approval, customer permission, security certification, regulatory approval, PHI processing approval, production connector approval, or live clinical care authorization. This brief is not a revenue guarantee, investment advice, securities offering material, audited financial report, valuation assurance, legal advice, tax advice, reimbursement assurance, procurement approval, customer permission, security certification, regulatory approval, PHI processing approval, production connector approval, or live clinical care authorization. ## Growth Plays - Founder-led assessment sprint (execute-now): Workflow Intelligence Assessment for Health system operations, access, documentation, transformation, and revenue-cycle leaders. Next: Run a weekly sponsor list, route qualified buyers to Pilot Intake, and package each call around one workflow pain plus one proof route. Boundary: No PHI, no live clinical execution, no savings guarantee, and no medical advice. - Synthetic Atlas pilot pipeline (execute-now): Synthetic Pilot Evaluation for Enterprise sponsors ready to test governed workflow intelligence before integration. Next: Use the Deal Room to frame pilot scope, review team, synthetic packet, decision metric, and protected workspace path. Boundary: Synthetic-only evidence until buyer-specific approvals, security review, and governance gates are retained. - AI governance audit wedge (package-next): AI Readiness + Governance Audit for Compliance, legal, privacy, security, clinical governance, and innovation leaders. Next: Create counsel-reviewable sales language and keep every certification or regulatory phrase behind external-review gates. Boundary: Readiness audit is not HIPAA certification, SOC 2 certification, HITRUST certification, legal approval, or FDA clearance. - Protected buyer diligence upgrade (protected-gated): Protected Buyer Diligence Room for Procurement, security, investor diligence, and executive buying committees. Next: Keep diligence packaging metadata-only until buyer-approved storage, access review, DLP, retention, and legal hold controls exist. Boundary: External sharing stays blocked until release decisions, reviewer signoffs, recipient controls, access logs, and customer permission are retained. - Public-sector and global partner program (external-review-required): Strategic Platform Partnership for Government health systems, sovereign programs, public-sector buyers, and qualified channel partners. Next: Pair every regional or public-sector conversation with qualified legal, privacy, security, procurement, and deployment review. Boundary: No regional legal approval, public-sector procurement approval, data-residency approval, or government endorsement claim. - Revenue-cycle proof wedge (package-next): Revenue workflow synthetic pilot for Payer, provider, and revenue-cycle leaders with denial, authorization, and documentation friction. Next: Package a no-PHI demonstration around one denial or prior-authorization support workflow and one buyer-approved value metric. Boundary: No final billing action, no payer submission, no reimbursement guarantee, and no audited financial impact claim. ## Conversion Lanes - Founder network and direct executive outreach: Visible operational pain, AI governance pressure, or transformation mandate. Entry: /product. Proof: /pilot-deal-room. Conversion: Pilot Intake submitted with named sponsor and workflow scope. - Product-led proof review: Buyer inspects demos, pricing, Trust Center, and proof routes before contacting SCRIMED. Entry: /demos. Proof: /pricing. Conversion: Buyer asks for pilot pricing, workflow evidence, or governance packet. - Governance and security review: AI risk, vendor diligence, BAA/DPA planning, claims control, or board scrutiny. Entry: /trust-center. Proof: /approvals-readiness. Conversion: Buyer asks for governance audit, evidence room, or protected pilot controls. - Investor, board, and advisor diligence: Category, moat, unit economics, customer proof, or growth strategy review. Entry: /capital-vitality. Proof: /growth-engine. Conversion: Reviewer asks for operating cadence, proof ladder, or commercial priorities. ## Revenue Proof Ladder - Public proof (ready): Can the buyer understand what SCRIMED is and why it is different? Metric: Qualified buyer moves to intake or executive review.. Gate: No public customer, clinical, revenue, securities, or certification overclaim. - Paid assessment (ready): Can SCRIMED sell a bounded first engagement without live data exposure? Metric: Assessment sponsor, workflow scope, and decision criteria retained.. Gate: No PHI, no medical advice, no guaranteed savings. - Synthetic pilot (measurement-required): Can SCRIMED prove workflow value through governed synthetic evidence? Metric: Synthetic work packet complete with reviewable outcome, Trust Card, and buyer decision route.. Gate: Buyer-approved metrics before external value claims. - Protected enterprise pilot (protected-gated): Can the buyer safely move from synthetic proof into controlled protected evaluation? Metric: Protected workspace and no-PHI packet controls active with retained AAL2 operator proof.. Gate: AAL2, external approvals, buyer permission, legal/privacy/security gates, and no-PHI evidence rules. - Enterprise license (external-review-required): Can SCRIMED expand into annual operating value after protected validation? Metric: Buyer-approved operating value, security posture, implementation scope, and license owner.. Gate: Customer contracts, security review, legal approval, connector approval, and production authority. ## Bottlenecks - Founder-led selling is still the fastest path (operator-required): SCRIMED has proof depth, but early enterprise conversion still needs direct founder narrative and qualification. Workaround: Run weekly target-account review, use Pilot Intake for every qualified call, and keep proof routes attached to each follow-up. Gate: Repeatable source-to-pilot conversion cohorts in Attribution Analytics. - Buyer proof cannot outrun retained approvals (protected-gated): The strongest enterprise proof is protected and cannot be shared publicly without release controls. Workaround: Use metadata-only public summaries and route buyer-specific artifacts through protected release-control and distribution lockbox gates. Gate: Release decisions, reviewer signoffs, recipient controls, and customer permission retained. - Revenue impact claims require buyer baselines (contained): Revenue-cycle value is compelling, but unsupported revenue claims can create legal, reimbursement, or investor risk. Workaround: Frame revenue impact as buyer-reviewed operational signal until protected buyer methodology and finance review exist. Gate: Buyer-approved baseline, finance methodology gate, and counsel-reviewed external-use language. - Fundraising and investor materials need counsel review (external-review-required): Capital readiness can be mistaken for offering material or investment advice. Workaround: Keep public routes readiness-only and route fundraising decks, valuation, securities language, tax, and legal questions through qualified counsel. Gate: Approved investor materials, controlled data-room process, and qualified securities counsel review. ## Next Growth Move Run founder-led assessment and synthetic-pilot outreach from /growth-engine, attach each conversation to one proof route, keep buyer-specific evidence protected, and route revenue, securities, legal, tax, valuation, reimbursement, PHI, security, connector, and live-care claims through retained external gates.